Bottom line
What is LHCFX's expense ratio?
LHCFX's expense ratio is 0.78%, or about $78 a year on every $10,000 invested. That is cheaper than 64% of health care sector funds we track (median 0.96%). It has no front-end sales load. Its expense ratio includes a 0.1% 12b-1 marketing fee.
Updated Feb 25, 2026
LHCFX fee table
| Net expense ratio | 0.78% |
|---|---|
| Gross expense ratio | 3.33% |
| Management fee | 0.62% |
| 12b-1 (distribution) fee | 0.1% |
| Other expenses | 2.61% |
| Fee waiver / reimbursement | -2.55% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 25, 2026
What LHCFX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| LHCFX | $80 | $785 | $1,515 | $3,448 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.78% expense ratio costs roughly $44,000 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).